Study of RTMS Analgesic Effect in Chronic Neuropathic Pain,
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Chronic Neuropathic Pain
In brief
The purpose of this study is to compare the analgesic effectiveness of three modes of repetitive Transcranial Magnetic Stimulation (rTMS) in chronic neuropathic pain: * Classical rTMS stimulation * Deeper rTMS stimulation * Sham rTMS stimulation
Key facts
- Study ID
- NCT04936646
- Run by
- University Hospital, Grenoble
- People needed
- 45
- Starts
- 2021-07-16
- Expected to finish
- 2025-12-01
- Last updated by the study team
- 2024-12-06
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient's written consent
- Affiliated with social security system
- Male or female, suffering for more than a year from unilateral refractory neuropathic pain: hemi-body, upper limb, lower limb and facial chronic pain.
- Patient whose analgesic treatment, is stable for at least 1 month.
- Patient not responding to conventional treatments
- Prescreening EVN >3
You may not qualify if…
- History of drug addiction, epilepsy, cranial trauma
- History of psychiatric disorder
- Patients previously treated with rTMS
- Patient with intracranial ferromagnetic material or implanted stimulator
- New treatment for less than one month
- Pregnant or Breastfeeding woman
- Patient who does not understand the study protocol
- Persons who are protected under the act.
Where it is running
- Centre de la douleur, CHU Grenoble Alpes — Grenoble, Isère, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.